VTAMA

This brand name is authorized in United States

Active ingredients

The drug VTAMA contains one active pharmaceutical ingredient (API):

1 Tapinarof UNII 84HW7D0V04 - TAPINAROF

Tapinarof is an aryl hydrocarbon receptor (AhR) agonist. The specific mechanisms by which tapinarof cream exerts its therapeutic action in psoriasis patients are unknown. Read about Tapinarof

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VTAMA Cream	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D05AX07		D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 81672-5051